3 Biotech Stocks Under $10 Surging Higher
SciClone Pharmaceuticals
SciClone Pharmaceuticals (SCLN), a specialty pharmaceutical company, has a product portfolio of therapies for oncology, infectious diseases, cardiovascular, urological, respiratory and central nervous system disorders. This stock is trading up 15.4% to $5.89 in recent trading.
Today's Range: $5.35-$5.94
52-Week Range: $3.41-$7.58 Volume: 1.15 million Three-Month Average Volume: 628,371 >>Hot Biotech Stocks Traded by Hedge Funds From a technical perspective, SCLN is ripping to the upside here back above its 200-day moving average of $5.46 with monster volume. This move is quickly pushing the stock within range of triggering a near-term breakout trade. That trade will hit once SCLN takes out some near-term overhead resistance at $6.04 with high volume. Traders should now look for long-biased trades once SCLN sustains a move or close above $6.04 with volume that's near or above 628,371 shares. If we get that action soon, then look for SCLN to re-test and possibly take out its 50-day moving average of $6.43. If that 50-day gets taken out with volume soon, then SCLN has a great chance of hitting its July high of $7.58.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV
